Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Adherium.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: The reason people quit weight-loss drugs
News
Top 10 at 11: Major gains for sustainable ag after Roots flies a shipment out of Israel
News
Top 10 at 10: Health minnow 1st Group climbs on new contract in WA
Health & Biotech
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go
Investor Guides
Investor Guide: Health & Biotech FY2023
News
Market Highlights: Powell speaks, ECB joins 75bp club, and 5 ASX small caps to watch on Friday
Health & Biotech
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
Health & Biotech
Check Up: ASX biotech comes alive as health stocks tackle international markets
News
Closing Bell: Late buyers save the ASX from its biggest daily fall of the year
News
ASX Small Cap Lunch Wrap: Who’s just riding the wave today?
Health & Biotech
ASX Health Stocks: Adherium races ahead 30pc on FDA clearance, Epsilon jumps 20pc on new cannabis partnership
News
10 at 10: These ASX stocks are the most in vogue with investor tastes this morning
Health & Biotech
These 3 ASX health stocks just took their next steps towards entering the USA
News
10 at 10: Investors are feeling festive for these ASX stocks this morning
Experts
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week
News